Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**5-fluorouridine** is a synthetic pyrimidine nucleoside analog in which the uracil base of uridine is substituted with a fluorine atom at the C‑5 position. It acts primarily as an antimetabolite and mutagen. In biological systems, it can be incorporated into RNA in place of uridine and disrupts normal RNA function and processing. Its main molecular target is uridine phosphorylase. While not approved for clinical use as an anticancer agent itself, it is structurally related to the widely used chemotherapeutic drug fluorouracil (5-FU), and often serves as a research tool for studying nucleic acid metabolism or comparing activity with other fluorinated pyrimidines[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-fluorouridine.